安踏(02020)FY22 业绩会纪要-港股-调研纪要
知乎(ZH US)4Q21E 稳健,FY22E 过渡
FY22E preview: page not yet turned
石四药集团:强劲的1H22结果;但FY22E指引略低
JS Global Lifestyle FY22E 起步缓慢,但正在改善
FY22业绩符合预期,温和复苏可期
华润医药:1H22业绩巩固了FY22E的正面
FY22收入8.84亿人民币,调后净利0.98亿派息率50%
FY22E preview: page not yet turned
FY22 results below; GPM recovery on better product mix